The Institute for Neurophysiopathology spinout has completed a series D round.

Vect-Horus, a France-based biotechnology developer spun out of Institute for Neurophysiopathology, has completed a €12m ($14.5m) series D round featuring undisclosed backers.
Vect-Horus is working on vectors that enable therapeutic molecules or imaging agents to be delivered to key organs. The money has been allocated to existing programmes, the development of additional vectors and technology validation.
The company emerged out of Institute for Neurophysiopathology, a joint research institute of Aix Marseille University and CNRS. It was founded in…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in